InsiderClue
← All stocks

NeuroSense Therapeutics Ltd.

NRSN Net buying
CIK 0001875091 #5177 in the set updated 18 Sep 2026
Bought (120 mo)
$400.00K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$400.00K
+$400.00K against sales at will

By person

4 insiders · 2 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ben-Noon Alon
Chief Executive Officer
$200.00K (1)
—
+$200.00K
4,534,233
13.93%
$3.63M
+5.8%
Eisenberg Or
Chief Financial Officer
$200.00K (1)
—
+$200.00K
1,504,050
4.62%
$1.20M
+42.7%
Binder Hagit
General Manager
—
—
—
521,806
1.60%
$417.44K
+62.1%
Russek-Blum Niva
Chief Technology Officer
—
—
—
467,953
1.44%
$374.36K
+74.6%

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
Eisenberg Or
16 Jun 2026
Chief Financial Officer
Buy
250,000
$0.80
$200.00K
Ben-Noon Alon
16 Jun 2026
Chief Executive Officer
Buy
250,000
$0.80
$200.00K

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 600,000
History held since 30 Mar 2026